Plasmon-Induced Photoreduction System Allows Ultrasensitive Detection of Disease Biomarkers by Silver-Mediated Immunoassay

The LOD paradox: When lower isn't always better in biosensor research and development

Biosensor research has long focused on achieving the lowest possible Limits of Detection (LOD), driving significant advances in sensitivity and opening up new possibilities in analysis. However, this intense focus on low LODs may not always meet the practical needs or suit the actual uses of these devices. While technological improvements are impressive, they can sometimes overlook important factors such as detection range, ease of use, and market readiness, which are vital for biosensors to be effective in real-world applications. This review advocates for a balanced approach to biosensor development, emphasizing the need to align technological advancements with practical utility. We delve into various applications, including the detection of cancer biomarkers, pathology-related biomarkers, and illicit drugs, illustrating the critical role of LOD within these contexts. By considering clinical needs and broader design aspects like cost-effectiveness, sustainability, and regulatory compliance, we argue that integrating technical progress with practicality will enhance the impact of biosensors. Such an approach ensures that biosensors are not only technically sound but also widely useable and beneficial in real-world applications. Addressing the diverse analytical parameters alongside user expectations and market demands will likely maximize the real-world impact of biosensors.

Optical nanomaterial-based detection of biomarkers in liquid biopsy

Liquid biopsy, which is a minimally invasive procedure as an alternative to tissue biopsy, has been introduced as a new diagnostic/prognostic measure. By screening disease-related markers from the blood or other biofluids, it promises early diagnosis, timely prognostication, and effective treatment of the diseases. However, there will be a long way until its realization due to its conceptual and practical challenges. The biomarkers detected by liquid biopsy, such as circulating tumor cell (CTC) and circulating tumor DNA (ctDNA), are extraordinarily rare and often obscured by an abundance of normal cellular components, necessitating ultra-sensitive and accurate detection methods for the advancement of liquid biopsy techniques. Optical biosensors based on nanomaterials open an important opportunity in liquid biopsy because of their enhanced sensing performance with simple and practical properties. In this review article, we summarized recent innovations in optical nanomaterials to demonstrate the sensitive detection of protein, peptide, ctDNA, miRNA, exosome, and CTCs. Each study prepares the optical nanomaterials with a tailored design to enhance the sensing performance and to meet the requirements of each biomarker. The unique optical characteristics of metallic nanoparticles (NPs), quantum dots, upconversion NPs, silica NPs, polymeric NPs, and carbon nanomaterials are exploited for sensitive detection mechanisms. These recent advances in liquid biopsy using optical nanomaterials give us an opportunity to overcome challenging issues and provide a resource for understanding the unknown characteristics of the biomarkers as well as the mechanism of the disease.

An electrochemiluminescence immunosensor based on multipath signal catalytic amplification integrated in a Cu2+-PEI-Pt/AuNC nanocomposite

Here, the nanocomposite Cu²⁺-PEI-Pt/AuNCs with multipath signal catalytic amplification for a peroxydisulfate-dissolved oxygen electrochemiluminescence (ECL) system was prepared to fabricate a sensitive ECL immunosensor. Using polyethyleneimine (PEI), a linear polymer, as the reductant and template, Pt/Au nanochains (Pt/AuNCs) were prepared. Abundant PEI would adsorb on the surface of Pt/AuNCs via Pt-N or Au-N bonds, and further coordinate with Cu²⁺ to give the final nanocomposite Cu²⁺-PEI-Pt/AuNCs which possessed multipath signal catalytic amplification for the ECL of the peroxydisulfate-dissolved oxygen system in the presence of H₂O₂. First, PEI, as an effective co-reactant, could directly enhance the ECL intensity. Second, Pt/AuNCs could not only act as a mimicking enzyme to promote the decomposition of H₂O₂ to produce more oxygen in situ, but also act as an effective co-reaction accelerator to facilitate the generation of more co-reactive intermediate groups from peroxydisulfate, resulting in an obviously enhanced ECL signal. Then, Cu²⁺ could also accelerate the decomposition of H₂O₂ to produce more oxygen in situ, leading to a further improvement of the ECL response. Using Cu²⁺-PEI-Pt/AuNCs as a loading platform, a sandwiched ECL immunosensor was fabricated. As a result, the obtained ECL immunosensor possessed an ultra-sensitive detection performance for α-1-fetoprotein, providing effective information on the diagnosis and treatment of related diseases.

Recent advances in nanotechnology-enhanced biosensors for α-fetoprotein detection

α-Fetoprotein (AFP) is a kind of fetal protein that is related to tumor, the increasing concentration of which gives birth to a large variety of diseases, such as liver cancer. Therefore, the detection method with super sensitivity, high selectivity, and less time consumption under trace concentrations in early stage of diseases is becoming a necessity. In recent years, nanomaterials have been regarded as significant resources for the exploration of efficient biosensors with high sensitivity, selectivity, speed, as well as simple process, due to their excellent optical, electrical, and chemical properties. In this paper, we reviewed the research progress of AFP biosensors with enhanced sensitivity and selectivity by nanoparticles. Representative examples have also been displayed in this paper to expound the nanotechnologies utilized in the early detection of AFP. Furthermore, challenges of the clinical application of AFP biosensors based on nanotechnology have been elaborated, as well as the development opportunity in this field in the future. This review provides a comprehensive overview on the various nano-biosensor for AFP detection based on functional nanotechnology.

Dual-mode sensing of biomarkers based on nano 3D Cu-Flo.@AuNPs-electrocatalyzed oxidation of glucose inducing in-situ H2O2-generation system

A bimodal 3D-electrochemiluminescence (ECL) analysis method was developed, which integrated simpleness, label-free, high-throughput and real time detection together. Firstly, a novel 3D copper-based nanosheet micro-material (Cu-Flo. NMs) coupled with gold nanoparticles/Cysteine (Cu-Flo.@AuNPs-Cys) was prepared to use as the versatile label for both colorimetric and ECL techniques. The 3D-Cu-Flo.@AuNPs-Cys having glucose oxidase-like activity could catalyze glucose to produce H₂O₂ in situ, which was further found to be capable of exhibiting a 30.95-fold higher ECL-intensity for luminol than bare glassy carbon electrodes (GCE). Taking advantages of the 3D-Cu-Flo.@AuNPs-Cys above, a colorimetric and ECL-channel sensor (GCE/3D-Cu-Flo.@AuNPs-Cys) were constructed simultaneously for glucose detection. The fabricated sensor displayed a wide linear range (Glucose: 0.001-50 mmol L^-1, AFP: 2.25 × 10^-7-225 ng mL^-1), impressive low limit of detection (Glucose: 1.27 × 10^-7 mol L^-1, AFP: 1.92 × 10^-8 ng mL^-1, S/N = 3) and acceptable recovery (Glucose: 94% ∼ 104%, AFP: 96.04% ∼ 102.29%) in practical sample. Furthermore, the biosensor showed ultrafast (0.5 min) analysis efficiency, high stability for 6 cyclic potential scans and satisfactory reproducibility for 7 repeated tests. These results demonstrated the proposed 3D dual-modal ECL-biosensor for biomarkers detection had a great potential in clinical diagnostics, promoting the application in biomedical researching and POCT.

Nitrogen-doped carbon dots/Ni-MnFe-layered double hydroxides (N-CDs/Ni-MnFe-LDHs) hybrid nanomaterials as immunoassay label for low-density lipoprotein detection

Nitrogen-doped carbon dots/Ni-MnFe-layered double hydroxides (N-CDs/Ni-MnFe-LDHs) are demonstrated as superior peroxidase mimic antibody labels alternative to horseradish peroxidase (HRP) in an immunoassay, potentially overcoming some of the inherent disadvantages of HRP and other enzyme mimicking nanomaterials. They revealed efficient peroxidase-like activity and catalyzed the oxidation of colorless 3,3',5,5'-tetramethylbenzidine (TMB) to form the intense blue product (at 620 nm) in the presence of hydrogen peroxide (H₂O₂). Using low-density lipoprotein (LDL) as a model target, an ultra-low limit of detection (0.0051 mg/dL) and a linear range of 0.0625-0.750 mg/dL were achieved, exhibiting higher sensitivity than the HRP-based immunoassay. Thus, the proposed N-CDs/Ni-MnFe-LDHs can be used as HRP mimicking analogs for developing highly sensitive colorimetric immunosensors for detection of biomarkers, as well as trace chemical analysis.

Alkaline Phosphatase-Triggered Etching of Au@FeOOH Nanoparticles for Enzyme Level Assay under Dark-Field Microscopy

In clinical diagnosis, the level of biological enzymes in serum has been generally regarded as markers of human diseases. In this work, a kind of simple and sensitive plasmonic probe (indicated as Au@FeOOH) has been synthesized with the guidance of plasmonic imaging and subsequently developed for the alkaline phosphatase (ALP) level detection under dark-field microscopy (DFM). As a kind of hydrolysis enzyme, ALP can promote the hydrolysis of l-ascorbic acid 2-phosphate to ascorbic acid (AA). AA further acts as a strong reduction reagent for the decomposition of the FeOOH shell, which results in a blue shift of localized surface plasmon resonance spectra and an obvious color change under DFM. RGB analyses show that using a ΔR/G value instead of scattering wavelength or R/G value as the analytical signal, the deviation attributed to the size distribution of the initial Au NPs is greatly suppressed, and a linear range from 0.2 to 6.0 U/L (R² = 0.99) and a limit of detection of 0.06 U/L are acquired with various concentrations of ALP during the detection. Besides, this approach exhibits excellent selectivity in complex biological serum samples, which is expected to be applied for the early diagnosis of clinical diseases by monitoring various biomarkers in the future.